for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Rigel Pharmaceuticals Q1 Loss Per Share $0.17

Rigel Pharmaceuticals Inc:

* RIGEL ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE

* Q1 LOSS PER SHARE $0.17

* Q1 EARNINGS PER SHARE VIEW $-0.18 -- THOMSON REUTERS I/B/E/S

* AS OF MARCH 31, HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $94.3 MILLION, VERSUS $115.8 MILLION AS OF DEC 31, 2017

* RIGEL - EXPECTS CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TO BE SUFFICIENT THROUGH AT LEAST NEXT 12 MONTHS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up